NO20003640L - Ny doseringsform - Google Patents

Ny doseringsform

Info

Publication number
NO20003640L
NO20003640L NO20003640A NO20003640A NO20003640L NO 20003640 L NO20003640 L NO 20003640L NO 20003640 A NO20003640 A NO 20003640A NO 20003640 A NO20003640 A NO 20003640A NO 20003640 L NO20003640 L NO 20003640L
Authority
NO
Norway
Prior art keywords
administered
dosage unit
food
outer coating
pharmaceutical
Prior art date
Application number
NO20003640A
Other languages
English (en)
Other versions
NO20003640D0 (no
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
West Pharmaceutical Service Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharmaceutical Service Dr filed Critical West Pharmaceutical Service Dr
Publication of NO20003640D0 publication Critical patent/NO20003640D0/no
Publication of NO20003640L publication Critical patent/NO20003640L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medikament og et ytre belegg som er utformet for å hindre frigivelse av medika- mentet i magen eller tynn-tarmen når den farmasøytiske dose-enheten er i nærvær av mat. Foreliggende oppfinnelse framskaffer videre en dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medika- ment og et ytre belegg, hvor belegget er laget av et materiale som er løselig ved pH-verdier under 5,0 og egnet for å skille den farmasøytiske dose-enheten fra sam- administrert mat. Den farmasøytiske dose-enheten er fortrinnsvis i form av en belagt tablett eller kapsel. Det er fordelaktig om det ytre belegget er en polymer. I tillegg angår foreliggende oppfinnelse en framgangsmåte for å separere oralt administrerte dose-enheter fra sam- administrert mat, og bruk av nevnte farmasøytiske dose- enheter innen medisin.
NO20003640A 1998-01-22 2000-07-14 Ny doseringsform NO20003640L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en) 1998-01-22 1999-01-20 Novel dosage form

Publications (2)

Publication Number Publication Date
NO20003640D0 NO20003640D0 (no) 2000-07-14
NO20003640L true NO20003640L (no) 2000-09-12

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003640A NO20003640L (no) 1998-01-22 2000-07-14 Ny doseringsform

Country Status (9)

Country Link
EP (1) EP1059918A1 (no)
JP (1) JP2002501016A (no)
AR (1) AR014467A1 (no)
AU (1) AU2176099A (no)
CA (1) CA2318257A1 (no)
GB (1) GB9801363D0 (no)
NO (1) NO20003640L (no)
WO (1) WO1999037290A1 (no)
ZA (1) ZA99454B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
SG175681A1 (en) 2006-10-25 2011-11-28 Proteus Biomedical Inc Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
EP3785599B1 (en) 2007-02-01 2022-08-03 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker systems
WO2008101107A1 (en) 2007-02-14 2008-08-21 Proteus Biomedical, Inc. In-body power source having high surface area electrode
EP2063771A1 (en) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. In-body device having a deployable antenna
WO2008112577A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
DK2215726T3 (en) 2007-11-27 2018-04-09 Proteus Digital Health Inc Transbody communication modules with communication channels
EP3235491B1 (en) 2008-03-05 2020-11-04 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems
EP2313002B1 (en) 2008-07-08 2018-08-29 Proteus Digital Health, Inc. Ingestible event marker data framework
CN102176862B (zh) 2008-08-13 2014-10-22 普罗透斯数字保健公司 可摄入电路
JP2012514799A (ja) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
GB2480965B (en) 2009-03-25 2014-10-08 Proteus Digital Health Inc Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
EP2432458A4 (en) 2009-05-12 2014-02-12 Proteus Digital Health Inc ACCEPTABLE EVENT MARKER WITH SUGAR COMPONENT
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
CN102905672B (zh) 2010-04-07 2016-08-17 普罗秋斯数字健康公司 微型可吞服装置
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
KR101898964B1 (ko) 2011-07-21 2018-09-14 프로테우스 디지털 헬스, 인코포레이티드 모바일 통신 장치, 시스템, 및 방법
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
CN104487347B (zh) 2012-07-23 2017-09-01 普罗秋斯数字健康公司 用于制造包括电子器件的片剂的方法和系统
CA2888871C (en) 2012-10-18 2016-08-09 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
JP6511439B2 (ja) 2013-06-04 2019-05-15 プロテウス デジタル ヘルス， インコーポレイテッド データ収集および転帰の査定のためのシステム、装置、および方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN109843149B (zh) 2016-07-22 2020-07-07 普罗秋斯数字健康公司 可摄入事件标记的电磁感测和检测
US10820831B2 (en) 2016-10-26 2020-11-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (zh) * 2018-10-16 2021-03-12 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮偶联分子的固体分散体及其应用
CN110613697A (zh) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 一种头孢氨苄胶囊及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants

Also Published As

Publication number Publication date
EP1059918A1 (en) 2000-12-20
WO1999037290A1 (en) 1999-07-29
JP2002501016A (ja) 2002-01-15
ZA99454B (en) 2000-10-23
NO20003640D0 (no) 2000-07-14
AU2176099A (en) 1999-08-09
GB9801363D0 (en) 1998-03-18
AR014467A1 (es) 2001-02-28
CA2318257A1 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
NO20003640L (no) Ny doseringsform
FI113336B (fi) Menetelmä tramadolisuolaa sisältävän lääkeaineen valmistamiseksi, jolla on viivästynyt vaikuttavan aineen vapautuminen
CA2144094A1 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
JP3633936B2 (ja) センナ剤形
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
HK1047226A1 (zh) 流体力学平衡口服药输送系统
MX9500885A (es) Preparacion farmaceutica para administracion oral.
AU1227899A (en) Osmotic medicament releasing system
ATE367802T1 (de) Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
JP2006016395A (ja) 薬物依存の処置に使用する薬物の安全な投与用の薬学的処方及び薬学的処方の取得方法
CA2383250A1 (en) Phytochemicals for treatment of mastalgia and endometriosis
TWI241195B (en) Preventive agent for bile acidic diarrhea
AR018582A1 (es) Forma de dosificacion en tableta para administrar un antagonista de los receptores de los leucotrienos y su uso en la preparacion de medicamentos
EP1217992A1 (en) Coated solid dosage forms
KR850700212A (ko) 서방성 약제학적 캼셀제
JPH0624959A (ja) 胃内浮遊型薬物徐放性固形製剤
FI89238C (fi) Foerfarande foer framstaellning av kompressionsbelagda tabletter
DK165123B (da) Fremgangsmaade til mekanisk bearbejdning af cobalt-holdige metaller samt med vand blandbart koncentrat til brug ved fremgangsmaaden
WO2007086079A3 (en) Sustained release dosage form of phenothiazine derivatives containing channelizer
RU2000114174A (ru) Применение фосфолипидных комплексов экстрактов из vitis vinifera в качестве противоатеросклеротических агентов
PL1643999T3 (pl) Pirydoksamina do zastosowania w leczeniu nefropatii cukrzycowej w cukrzycy typu II
Allen et al. Effect of single dose of omeprazole on the gastrointestinal peptide response to food
EP4125850B1 (en) Sodium butyrate for use in the prevention or treatment of rhinovirus infection
RU2007116726A (ru) Применение лавандового масла для профилактики и лечения неврастении, соматических нарушений и других болезней, связанных со стрессом

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application